Growth Metrics

Volitionrx (VNRX) Revenue (2012 - 2025)

Volitionrx posted quarterly Revenue of -$3771.0 for Q4 2025, up 89.66% year-on-year from -$1988.3 in Q4 2024, and down 100.7% on a QoQ basis from $538381.0 in Q3 2025.

Volitionrx (VNRX) has 8 years of Revenue data on file, last reported at -$3771.0 in Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 89.66% year-over-year to -$3771.0; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (up 26.76% YoY), and the FY2025 full-year result was $1.3 million, up 26.98% from the prior year.
  • Revenue for Q4 2025 stood at -$3771.0, down from $538381.0 in the prior quarter.
  • Across five years, Revenue topped out at $538381.0 in Q3 2025 and bottomed at -$36481.0 in Q4 2024.
  • The 5-year median for Revenue is $134761.5 (2022), against an average of $164817.6.
  • The widest annual swing landed in 2021, when Revenue jumped 8298.03%; it then sank 114.95% in 2024.
  • A 5-year view of Revenue shows it stood at $14240.0 in 2021, then jumped by 740.7% to $119715.0 in 2022, then jumped by 103.79% to $243973.0 in 2023, then tumbled by 114.95% to -$36481.0 in 2024, then jumped by 89.66% to -$3771.0 in 2025.
  • The last three Revenue figures came in at -$3771.0 (Q4 2025), $538381.0 (Q3 2025), and $406688.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 11.16 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.02 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.65 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.19 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.59 Bn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn -3,771.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -3,771.00
Sep 30, 2025 538,381.00
Jun 30, 2025 406,688.00
Mar 31, 2025 246,385.00
Dec 31, 2024 -36,481.00
Sep 30, 2024 406,088.00
Jun 30, 2024 395,797.00
Mar 31, 2024 171,535.00
Dec 31, 2023 243,973.00
Sep 30, 2023 165,211.00
Jun 30, 2023 216,310.00
Mar 31, 2023 149,808.00
Dec 31, 2022 119,715.00
Sep 30, 2022 32,714.00
Jun 30, 2022 39,752.00
Mar 31, 2022 114,211.00
Dec 31, 2021 14,240.00
Sep 30, 2021 25,483.00
Jun 30, 2021 24,782.00
Mar 31, 2021 25,530.00
Dec 31, 2020 7,120.00
Sep 30, 2020 575.00
Jun 30, 2020 5,194.00
Mar 31, 2020 304.00
Dec 31, 2019 17,096.00
Sep 30, 2012 27,589.00
Jun 30, 2012 11,707.00
Mar 31, 2012 15,672.00